Seelos Therapeutics, Inc. Made Headway

Fri, Mar 12, 2021 at 05:33 PM
Seelos Therapeutics, Inc. Made Headway

Seelos Therapeutics, Inc. (SEEL:NASDAQ) soared at $4.75, representing a gain of 56.3%. On Thu 11 Mar 21, SEEL:NASDAQ touched a New 2-Week Intraday High of $3.14. The stock appeared on our News Catalysts scanner on Fri 05 Mar 21 at 10:39 AM in the 'BIOTECH' category. From Thu 25 Feb 21, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Tue 16 Feb 21 at $4.44 with a volume of 5M+, and its share price has been moving sideways in recent weeks.

About Seelos Therapeutics, Inc. (SEEL:NASDAQ)

Apricus Biosciences Inc is engaged in the pharmaceutical industry. The company develops and commercializes products and product candidates in the areas of urology and rheumatology. Apricus' drug delivery technology is a permeation enhancer called NexACT. The company has over two product candidates in Phase II development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa for the treatment of Raynaud's phenomenon.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.